Editorial
|
|
|
|
|
An illuminating approach worth applying to healthcare
|
|
|
|
Marketing Authorisations
|
|
|
|
|
Multiple myeloma: too toxic!
|
|
|
|
|
|
|
|
|
|
|
|
Don't rely too heavily on this dabigatran antidote
|
|
|
|
|
|
|
|
|
|
A few extra months of life but slightly more toxic
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Angiogenesis inhibitors in cancer affect healthy tissues
|
|
|
|
|
|
|
|
|
|
All opioids are implicated
|
|
|
|
|
|
|
|
|
|
|
|
Watch out for high-risk situations
|
|
|
|
Reviews
|
|
|
|
|
Useful medications for patients with recurrent symptoms
|
|
|
|
|
|
Outlook
|
|
|
|
|
French opinion leaders and regulators in the hot seat
|
|
|
|
|
|